These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30696332)

  • 21. Characteristics and definitions of ultra-treatment-resistant schizophrenia - A systematic review and meta-analysis.
    Campana M; Falkai P; Siskind D; Hasan A; Wagner E
    Schizophr Res; 2021 Feb; 228():218-226. PubMed ID: 33454644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia.
    Arumugham SS; Thirthalli J; Andrade C
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1245-52. PubMed ID: 27322602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine resistant schizophrenia: Newer avenues of management.
    Chakrabarti S
    World J Psychiatry; 2021 Aug; 11(8):429-448. PubMed ID: 34513606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When symptoms persist: clozapine augmentation strategies.
    Buckley P; Miller A; Olsen J; Garver D; Miller DD; Csernansky J
    Schizophr Bull; 2001; 27(4):615-28. PubMed ID: 11824488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
    Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
    J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.
    Wang G; Zheng W; Li XB; Wang SB; Cai DB; Yang XH; Ungvari GS; Xiang YT; Correll CU
    J Psychiatr Res; 2018 Oct; 105():23-32. PubMed ID: 30144667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The augmentation of clozapine treatment with electroconvulsive therapy.
    Gazdag G; Kocsis-Ficzere N; Tolna J
    Ideggyogy Sz; 2006 Jul; 59(7-8):261-7. PubMed ID: 17076304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Refractory schizophrenia].
    Elkis H; Meltzer HY
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S41-7. PubMed ID: 18157433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance is not futile: treatment-refractory schizophrenia - overview, evaluation and treatment.
    Faden J; Citrome L
    Expert Opin Pharmacother; 2019 Jan; 20(1):11-24. PubMed ID: 30407873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Roukas DK
    Eur Psychiatry; 2005 Aug; 20(5-6):409-15. PubMed ID: 16171655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychopharmacological treatment of treatment-resistant schizophrenia].
    Lublin HK
    Ugeskr Laeger; 1997 Nov; 159(48):7128-33. PubMed ID: 9417718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.
    Stubbs JH; Haw CM; Staley CJ; Mountjoy CQ
    Acta Psychiatr Scand; 2000 Nov; 102(5):390-3; discussion 393-4. PubMed ID: 11098812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schizophrenia: when clozapine fails.
    Miyamoto S; Jarskog LF; Fleischhacker WW
    Curr Opin Psychiatry; 2015 May; 28(3):243-8. PubMed ID: 25768082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.
    Greenhalgh J; Knight C; Hind D; Beverley C; Walters S
    Health Technol Assess; 2005 Mar; 9(9):1-156, iii-iv. PubMed ID: 15774232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Cao XL; Ungvari GS; Xiang YQ; Guo T; Liu ZR; Wang YY; Forester BP; Seiner SJ; Xiang YT
    PLoS One; 2016; 11(6):e0156510. PubMed ID: 27285996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
    Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
    J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.